Board of Directors
Frederick W. Telling
Chairman of the Board
Dr. Telling has served as a Director since June 2010 and became Chairman in February 2011. Dr. Telling retired from Pfizer Inc. in June 2007 after 30 years of service as its Corporate Vice President and Vice President of Corporate Strategic Planning and Policy. He also serves as a director and member of the Compensation Committee and Audit Committee at Cell Therapeutics Inc., a public company based in Seattle, Washington. Dr. Telling holds a B.A. degree in History and Economics from Hamilton College and a MA degree in Industrial and Labor Relations and a PhD in Economics and Public Policy from Cornell University.
Charles L. Pope
Mr. Pope has served as a Director and Chairman of the Audit Committee since June 2010. Mr. Pope has also served as the Chairman of the Nominating and Corporate Governance Committee since July 2015. He was the Chief Financial Officer of Palm Bancorp, Inc. from June 2009 to April 2012 and from September 2007 through June 2009, Mr.Pope served as the Chief Financial Officer of Aerosonic Inc., a manufacturer of aviation products. He currently serves on the board of directors of Inuvo, Inc. in Clearwater, Florida and served on the board of directors of Innovaro Inc. in Tampa, Florida until 2012. Mr. Pope holds a B.S. degree in Economics and Accounting from Auburn University and is a Certified Public Accountant in Florida.
|Nominating and Corporate Governance Committee||Chair|
Dr. Alan W. Dunton has served as a Director since June 2010 and became Chairman of the Compensation Committee in July 2015. Dr. Dunton is also the principal owner of Danerius, LLC, a biotechnology consulting company which he founded in 2006. He is on the Board of Directors at Targacept, Inc., Palatin Technologies, Inc., and Sancilio & Company, Inc. and holds a MD degree from New York University School of Medicine, where he completed his residency in internal medicine.
Mr. Koski has served as a Director since June 2009. Mr. Koski has practiced as an attorney with the Koski Firm, a sole proprietorship located in Atlanta, Georgia since 1992, where his practice includes litigation and tax law. Mr. Koski has also served as a partner in the Koski Family Limited Partnership, which beneficially owns a controlling interest in the Company, and as a director of the Koski Family Foundation since December 1996. He holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University. He is also the brother of one of our other Directors, Christine Koski.
Alan Joslyn, Ph.D.
President and Chief Executive Officer
Dr. Joslyn was a partner in Lazarus Pharmaceuticals. Prior to that he served as the Chief Executive Officer and Director of several privately held companies including Edusa Pharmaceuticals and Sentinella Pharmaceuticals and prior to that he was the Senior Vice-President Research and Development of Penwest Pharmaceuticals and also held senior drug development positions with Johnson & Johnson.